Press release

Press release

August 26, 2016

2016 Half-year Report published

Follicum has today published the Half-year  Report for the period  1 January to  30 June, 2016. The report is available in Swedish only. Open the full report For more information please contact: Jan Alenfall, CEO Phone: +46 (0)46 19 21 97 Email:  

June 20, 2016

Follicum AB receives patent is approved in the USA

Follicum announce that the patent application entitled “Novel Compositions and Uses Thereof”, covering the drug candidate FOL-005 and related compounds, has now been formally approved by the US Patent and Trademark Office (“USPTO”). Granting of this patent, number US 9,381,149, follows the “Intention to Grant” communicated on 11 March 2016. The administrative process at the USPTO regarding […]

June 13, 2016

Summary of the Annual General Meeting

On 13 June 2016 the Annual General Meeting was held in Follicum AB. The report is only available in Swedish. For more information, please contact: Jan Alenfall, CEO Tel: +46 (0)46 19 21 97 Email:

May 30, 2016

Q1 2016 Interim Report published

First quarter  (2016-01-01  –  2016-03-31) Other operating income amounted to SEK 0  (SEK 0). Profit after financial items amounted to -5,270 TSEK (-5,609 TSEK). Earnings per share amounted to approximately -0.53 SEK (-0.63 SEK). The equity ratio amounted to approximately 82.3% (89.9%). See full Interim Report Q1 2016 (in Swedish) Definitions Earnings per share: Net […]

May 25, 2016

Last day of trading in FOLLI BTA

Last day of trading in the company´s paid subscribed share, FOLLI BTA is May 30, 2016. Information about the paid subscribed share: Shortname: FOLLI BTA ISIN-code: SE0008242895 Orderbook-ID: 121123 Last day of trading: May 30, 2016 Information in Swedish For more information, please contact AktieTorget phone +46 (0)8 511 68 000 or by e-mail […]

May 16, 2016

Follicum’s rights issue fully subscribed

On May 10,  2016,  the subscription period for the rights issue in Follicum AB for a maximum of  30 MSEK closed. Including subscriptions and guaranteed commitments, the rights issue was subscribed by around 110 percent, to a level of approximately SEK 32.9 million. Follicum aimed to raise approximately 30 MSEK of additional capital, before rights […]

May 13, 2016

Notice of Annual General Meeting

The shareholders of Follicum AB (publ), 556851-4532, are invited to the Annual General Meeting,  on Monday, June 13, 2016 at 10:00 a.m. (CEST), at Scheelevägen 22, Lund. A shareholder, who wishes to participate in the meeting, must: Be recorded as shareholder (not nominee registered) in the share register held by Euroclear Sweden AB on Tuesday, […]

May 3, 2016

Follicum patent granted, by European Patent Office

This official patent approval protects the company’s peptides for hair growth stimulation, and provides European protection until 2032. Granting of this patent, number EP12768879.4, follows the “Intention to Grant” communicated on 1 October 2015. CEO Jan Allenfal commented: – This is an important step for us, the patent provides protection for our peptides in Europe, […]

April 25, 2016

Publication of prospectus supplement

Follicum announces publication of a supplement to the prospectus, due to publication of a press release on 18 April 2016 (Swedish) and available in English on 21 April 2016. The Prospectus was approved and registered by the Swedish Financial Supervisory April 13 2016, with an invitation to subscribe for shares from 21 April to 10 […]